Prevalence of anxiety and depression in patients with rheumatoid arthritis before and during the COVID-19 pandemic

Rheumatology (Oxford). 2021 Apr 6;60(4):2023-2024. doi: 10.1093/rheumatology/keab065.

Authors

Takahiro Itaya¹, Mie Torii², Motomu Hashimoto³, Kyosuke Tanigawa², Yuki Urai², Ayae Kinoshita², Kazuko Nin², Kazuaki Jindai¹, Ryu Watanabe³, Koichi Murata^{3

4}, Kosaku Murakami⁵, Masao Tanaka³, Hiromu Ito^{3

4}, Shuichi Matsuda⁴, Akio Morinobu⁵

Affiliations

¹ Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health.
² Department of Human Health Sciences.
³ Department of Advanced Medicine for Rheumatic Diseases.
⁴ Department of Orthopaedic Surgery, Graduate School of Medicine.
⁵ Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antirheumatic Agents / therapeutic use*
Anxiety* / diagnosis
Anxiety* / epidemiology
Anxiety* / physiopathology
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / epidemiology
Arthritis, Rheumatoid* / psychology
COVID-19* / epidemiology
COVID-19* / psychology
Depression* / diagnosis
Depression* / epidemiology
Depression* / physiopathology
Female
Humans
Japan / epidemiology
Male
Mental Health / trends
Needs Assessment
Psychiatric Status Rating Scales
Risk Assessment

Substances

Antirheumatic Agents